Lisa Geller

Biography

Lisa Geller has over 25 years of experience practicing intellectual property law and strategy.  She is the principal of Intellectual Property Strategy, LLC, and advises life science and pharmaceutical companies on all aspects of intellectual property including patents, trademarks, and trade secrets, emphasizing both short- and long-term strategies and integration of global intellectual property strategy with business plans.  She works with scientists and entrepreneurs to identify inventions, advising on potential pathways to maximize the utility of patents covering inventions, and working with teams to bridge and coordinate the technical and business aspects of a company.

Dr. Geller served as Senior Vice President for Intellectual Property at Frequency Therapeutics and was Head of Intellectual Property at Casebia Therapeutics, Seres Therapeutics, and other innovator companies managing comprehensive intellectual property portfolios.  She also served as an Associate General Counsel at Biogen Idec, managing the patent portfolios for drugs in all stages of development, from R&D to commercial blockbuster drugs.  Before joining Biogen Idec, Dr. Geller practiced patent law in the law firms of Fish & Richardson P.C. and Wilmer Hale, where her practice included all aspects of patent law including client counseling and licensing, primarily in the areas of biotechnology and pharmaceuticals.

Dr. Geller received her PhD in biology from the University of California, Los Angeles, and was a post-doctoral fellow and faculty member in the Department of Neurobiology at Harvard Medical School. She received her JD degree from Boston University School of Law, where she teaches a seminar on patent prosecution.

Dr. Geller is also on the editorial advisory board of Science and Engineering Ethics and has published in on topics related to the interface between social issues and science as well as participating in multiple programs related to supporting diversity in science and law.